UC's $15 million to fight opioid deaths makes local headlines
A recap of media coverage following the HHS' HEALing Communities announcement
On Thursday, April 18, Health and Human Services (HHS) Secretary Alex Azar announced the launch of the HEALing Communities Study to help reverse our nation’s opioid crisis. Four states – Ohio, Kentucky, Massachusetts and New York, will receive over $350 million to support a multi-year study with the goal to cut opioid overdose deaths by 40% in three years. The announcement made news across Ohio and the region.
Funded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), University of Cincinnati and Ohio State University will co-lead a $65.9 million effort across Ohio that will also partner with Recovery Ohio and Case Western Reserve University as well as additional universities and community organizations in 19 counties across Ohio. UC will be awarded $15.1 million over four years. Read the full story here.
HEALing Communities Award in the news:
WLW-700 AM(interview at 69:25 minute mark.)
Featured image at top: Jennifer Brown, PhD, presents at the UC / UC Health Opioid Symposium. Photo by Colleen Kelley/AHC Communication Services.
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.